<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31752055</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1738-8872</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of microbiology and biotechnology</Title><ISOAbbreviation>J Microbiol Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Salvianolic Acid B Inhibits Hand-Foot-Mouth Disease Enterovirus 71 Replication through Enhancement of AKT Signaling Pathway.</ArticleTitle><Pagination><StartPage>38</StartPage><EndPage>43</EndPage><MedlinePgn>38-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4014/jmb.1907.07079</ELocationID><Abstract><AbstractText>Hand, foot, and mouth disease (HFMD) is caused by enterovirus 71 (EV71) in infants and children under six years of age. HFMD is characterized by fever, mouth ulcers, and vesicular rashes on the palms and feet. EV71 also causes severe neurological manifestations, such as brainstem encephalitis and aseptic meningitis. Recently, frequent outbreaks of EV71 have occurred in the Asia-Pacific region, but currently, no effective antiviral drugs have been developed to treat the disease. In this study, we investigated the antiviral effect of salvianolic acid B (SalB) on EV71. SalB is a major component of the <i>Salvia miltiorrhiza</i> root and has been shown to be an effective treatment for subarachnoid hemorrhages and myocardial infarctions. HeLa cells were cultured in 12-well plates and treated with SalB (100 or 10 &#xb5;g/ml) and 10<sup>6</sup> PFU/ml of EV71. SalB treatment (100 &#xb5;g/ml) significantly decreased the cleavage of the eukaryotic eIF4G1 protein and reduced the expression of the EV71 capsid protein VP1. In addition, SalB treatment showed a dramatic decrease in viral infection, measured by immunofluorescence staining. The Akt signaling pathway, a key component of cell survival and proliferation, was significantly increased in EV71-infected HeLa cells treated with 100 &#xb5;g/ml SalB. RT-PCR results showed that the mRNA for anti-apoptotic protein Bcl-2 and the cell cycle regulator Cyclin-D1 were significantly increased by SalB treatment. These results indicate that SalB activates Akt/PKB signaling and inhibits apoptosis in infected HeLa cells. Taken together, these results suggest that SalB could be used to develop a new therapeutic drug for EV71-induced HFMD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>So-Hee</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun, Chungbuk 28024, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jihye</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 120-750, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Ye Lin</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun, Chungbuk 28024, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Aerum</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate School of Industrial Pharmaceutical Sciences, Ewha Womans University, Seoul 120-750, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nam</LastName><ForeName>Sang-Jip</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 120-750, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Byung-Kwan</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun, Chungbuk 28024, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Microbiol Biotechnol</MedlineTA><NlmUniqueID>9431852</NlmUniqueID><ISSNLinking>1017-7825</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001572">Benzofurans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>C1GQ844199</RegistryNumber><NameOfSubstance UI="C076944">salvianolic acid B</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001572" MajorTopicYN="N">Benzofurans</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D027561" MajorTopicYN="N">Salvia miltiorrhiza</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Salvianolic acid B</Keyword><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">enterovirus71</Keyword><Keyword MajorTopicYN="N">hand-foot-mouth disease</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword></KeywordList><CoiStatement>
<b>Conflict of Interest</b>
. The authors have no financial conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31752055</ArticleId><ArticleId IdType="pmc">PMC9728356</ArticleId><ArticleId IdType="doi">10.4014/jmb.1907.07079</ArticleId><ArticleId IdType="pii">10.4014/jmb.1907.07079</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang QQ, Zhai C, Wahafu A, Zhu YT, Liu YH, Sun LQ. Salvianolic acid B inhibits the development of diabetic peripheral neuropathy by suppressing autophagy and apoptosis. J. Pharm. Pharmacol. 2019;71:417&#x2013;428. doi: 10.1111/jphp.13044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jphp.13044</ArticleId><ArticleId IdType="pubmed">30537209</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P, Hu YY, Liu C, Zhu DY, Xue HM, Xu ZQ, et al. Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. World J. Gstroenterol. 2002;8:679&#x2013;685. doi: 10.3748/wjg.v8.i4.679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v8.i4.679</ArticleId><ArticleId IdType="pmc">PMC4656320</ArticleId><ArticleId IdType="pubmed">12174378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Wu CH, Luo MH, Huang YJ, Wang CN, Shiao MS, et al. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J. Ethnopharmacol. 2006;105:215&#x2013;222. doi: 10.1016/j.jep.2005.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2005.10.021</ArticleId><ArticleId IdType="pubmed">16314058</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YH, Du GH, Zhang JT. Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Acta Pharmacol. Sin. 2000;21:463&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">11324448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao GR, Zhang HM, Ye TX, Xiang ZJ, Yuan YJ, Guo ZX, et al. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem. Toxicol. 2008;46:73&#x2013;81. doi: 10.1016/j.fct.2007.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2007.06.034</ArticleId><ArticleId IdType="pubmed">17719161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YH, Lin SJ, Ku HH, Shiao MS, Lin FY, Chen JW, et al. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J. Cell Biochem. 2001;82:512&#x2013;521. doi: 10.1002/jcb.1176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.1176</ArticleId><ArticleId IdType="pubmed">11500927</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. Crystal structure of human enterovirus 71. Science. 2012;336:1274. doi: 10.1126/science.1218713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Lai JK, Sam IC, Chan YF. Recent developments in antiviral agents against enterovirus 71 infection. J. Biomed. Sci. 2014;21:14. doi: 10.1186/1423-0127-21-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-14</ArticleId><ArticleId IdType="pmc">PMC3924904</ArticleId><ArticleId IdType="pubmed">24521134</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M, Luo H, Yanagawa B, Suarez A, Dabiri D, Zhang J, et al. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J. Virol. 2004;78:4289&#x2013;4298. doi: 10.1128/JVI.78.8.4289-4298.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.8.4289-4298.2004</ArticleId><ArticleId IdType="pmc">PMC374262</ArticleId><ArticleId IdType="pubmed">15047842</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YG, Park JH, Jeon ES, Kim JH, Lim BK. Fructus amomi cardamomi extract inhibit coxsackievirus-B3 induced myocarditis in murine myocarditis model. J. Microbiol. Biotechnol. 2016;26:2012&#x2013;2018. doi: 10.4014/jmb.1605.05056.</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.1605.05056</ArticleId><ArticleId IdType="pubmed">27558433</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim BK, Yun SH, Ju ES, Kim BK, Lee YJ, Yoo DK, et al. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model. Virus Res. 2015;199:1&#x2013;8. doi: 10.1016/j.virusres.2014.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.11.030</ArticleId><ArticleId IdType="pubmed">25485472</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JY, Jeong HI, Park CW, Yoon J, Ko J, Nam SJ, et al. Cholic acid attenuates ER stress-induced cell death in coxsackievirus-B3 infection. J. Microbiol. Biotechnol. 2018;28:109114. doi: 10.4014/jmb.1708.08009.</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.1708.08009</ArticleId><ArticleId IdType="pubmed">29032641</ArticleId></ArticleIdList></Reference><Reference><Citation>Castello A, Alvarez E, Carrasco L. Differential cleavage of eIF4GI and eIF4GII in mammalian cells. Effects on translation. J. Biol. Chem. 2006;281:33206&#x2013;33216. doi: 10.1074/jbc.M604340200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M604340200</ArticleId><ArticleId IdType="pubmed">16959778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Lee KH, Park KH, Moon JH. Large scale isolation and purification of salvianolic acid B in high purity from roots of Dansham (Salvia miltiorrhiza Bunge) Food Sci. Biotechnol. 2010;19:497&#x2013;502. doi: 10.1007/s10068-010-0069-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10068-010-0069-z</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>